Preclinical Imaging In-VIVO Systems and Reagents Market is Expected to Exceed US $ 960 Million By 2024

New York, August 17, 2018: The scope of the report includes a detailed study of global and regional markets for Global Preclinical Imaging In-VIVO Systems and Reagents Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, MR Solutions Ltd., Mediso Ltd., Milabs B.V., MiltenyiBiotec GmbH, Perkinelmer and Trifoil Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The preclinical imaging in vivo systems and reagents Market is expected to exceed more than US $ 960 million by 2022 and will grow at a CAGR of more than 6% in the given forecast period.

Preclinical imaging is the visualization of residing animals for studies purposes, which include drug development. Imaging modalities have long been critical to the researcher in observing modifications, both at the organ, tissue, mobile, or molecular level, in animals responding to physiological or environmental modifications. Imaging modalities which are non-invasive and In-VIVO have turn out to be particularly critical to take a look at animal fashions longitudinally. These imaging systems may be labeled into commonly morphological/anatomical and commonly molecular imaging techniques. Strategies along with high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are normally used for anatomical imaging. Whilst optical imaging (fluorescence and bioluminescence), positron emission tomography (puppy), and single photon emission computed tomography (SPECT) are typically used for molecular visualizations.

Browse Full Report:

The Global Preclinical Imaging In-VIVO Systems and Reagents Market is Segmented on the lines of By Modality Analysis, By Reagents Analysis and By Regional Analysis. By Modality Analysis this market is segmented on the basis of Optical Imaging Systems, Standalone Fluorescence Imaging Systems, Bioluminescence/Fluorescence Imaging Systems, Optical + X-Ray/Optical + CT, Micro-PET Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Trimodality (SPECT/PET/CT) Systems, Micro-SPECT Systems Micro-CT Systems, Micro-Ultrasound Systems, Preclinical Magnetic Particle Imaging (MPI) Systems and Preclinical Photo acoustic Imaging Systems.

By Reagents Analysis this market is segmented on the basis of Preclinical Optical Imaging Reagents, Fluorescent Imaging Reagents, Bioluminescent Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical SPECT Probes, Preclinical MRI Contrast Agents, Preclinical PET Tracers, Gadolinium-based Preclinical MRI Contrast Agents, Manganese-based Preclinical MRI Contrast Agents, Iron-based Preclinical MRI Contrast Agents, Preclinical CT Contrast Agents, Barium-based Preclinical CT Contrast Agents, Preclinical Ultrasound Contrast Agents, Gold Nano particles, Iodine-based Preclinical CT Contrast Agents and Gastrografin-based Preclinical CT Contrast Agents. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Preclinical Imaging In-VIVO Systems and Reagents Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Preclinical Imaging in Vivo Systems and Reagents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Preclinical Imaging IN-VIVO Systems and Reagents Market are as follows:

  • Technical advancements in the area of molecular imaging
    • Growing market demand for noninvasive small animal imaging techniques
    • Increasing number of public and private initiative and financial support to support preclinical researches

The restraining factors of Global Preclinical Imaging In-VIVO Systems and Reagents Market are as follows:

• Strict rules leading preclinical research
• Major installation and operational cost related with preclinical

Request Sample Report from here:


Table of Contents



2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Preclinical Imaging Market Overview

6 Industry Insights

7 Global Preclinical Imaging Market, By Modality

8 Global Preclinical Imaging Market, By Reagent

9 Preclinical Imaging Market, By Region

10 Competitive Landscape

11 Company Profiles

11.1 Introduction

11.2 Perkinelmer, Inc.

11.3 Bruker Corporation

11.4 Fujifilm Holdings Corporation

11.5 Mediso Ltd.

11.6 Milabs B.V.

11.7 MR Solutions Ltd.

11.8 Aspect Imaging Ltd.

11.9 Li-Cor Biosciences

11.10 Trifoil Imaging

11.11 Miltenyi Biotec GmbH


Other Related Market Research Reports:

Point-of-Care Testing (POCT) Market is Forecast to Cross US$ 35 Billion By 2024

Q-PCR and D-PCR Devices Market is Supposed to Reach US$ 4.50 Billion By 2024

Prefilled Syringes Market is Expected to Get US$ 6.00 Billion by 2022


Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States


The post Preclinical Imaging In-VIVO Systems and Reagents Market is Expected to Exceed US $ 960 Million By 2024 appeared first on Herald Keeper.

Add Comment